Chao-Min Cheng received his Ph. D. in Biomedical Engineering in 2009 from Carnegie Mellon University under the supervision of Prof. Philip R. LeDuc. He then did his post-doctoral training with Prof. George M. Whitesides at Harvard University where he helped develop paper diagnostic devices to address global public health concerns. He is currently an independent P.I., tenured Associate Professor, at National Tsing Hua University, Taiwan, where he started in the summer of 2011. He has been blessed to receive the Distinguished Young Investigator Research Grant twice from the Ministry of Science and Technology in Taiwan, and was awarded “Excellent Performance on Intellectual Property & Technology Transfer” by his school twice (2012 & 2013). He is currently an Acting Member of the International Affairs/Globalization Committee for the Biomedical Engineering Society (BMES), an Editorial Board Member for Sensor Letters, Journal of Cellular and Molecular Medicine, and Scientific Reports. In addition to his many academic contributions, Dr. Cheng serves as a consultant for biotechnologically relevant companies around the world with approximately 25 patent groups either granted or pending (in Taiwan, China, U.S.), and is the co-Founder of start-up companies in Taiwan and the U.S.